Patent · US Expired

Anti-human medullasin monoclonal antibody process for producing the same and immunoassay using the same

US6764827B1 · kind B1 · utility

9Cited by
1References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 27, 1999
Grant dateJul 20, 2004
Priority date
Expiry dateAug 27, 2019

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S530/861
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

A monoclonal antibody by which medullasin that is a kind of serine proteases existing in granulocytes, production process thereof and an immunoassay of human medullasin using the antibody are disclosed. The monoclonal antibody specifically recognizes human medullasin. The process for producing the anti-human medullasin antibody comprises culturing hybridomas prepared by cell fusion between antibody-producing cells recovered from an animal immunized with human medullasin and myeloma cells, and recovering anti-human medullasin monoclonal antibody which specifically recognizes human medullasin from the culture in which the hybridomas are cultured. The immunoassay utilizes the anti-human medullasin antibody.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.